English Journal

[Supplemental Fuzhenghuayu capsule therapy for improving liver fibrosis markers in patients with chronic hepatitis B following unsatisfactory outcome of nucleos(t)ide analogue monotherapy.]

Tian YL, Zhu XY, Yin WW, Zang ZD, Wang L, Fu XL.SourceDepartment of Liver Diseases, Second Affiliated Hospital of Southeast University, Second Hospital of Nanjing, Nanjing 210003, China.
Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology.Zhonghua Gan Zang Bing Za Zhi.2013 Jul;21(7):514-518. doi: 10.3760/cma.j.issn.1007-3418.2013.07.010.
OBJECTIVE: To investigate the ability of Fuzhenghuayu capsule to improve markers of liver fibrosis when provided as supplemental therapy in patients with chronic hepatitis B (CHB) who achieved complete virological response but unsatisfactory resolution of fibrosis markers with nucleos(t)ide analog (
PMID 24074710

[Clinical efficiency of tanshinone IIA-sulfonate in treatment of liver fibrosis of advanced schistosomiasis].

Niu XH, Hua HY, Guo WJ, Zhang Y, Liu M, Hong Y, Wu PF, Lu P, Zhang HF.SourceThird People's Hospital of Kunshan, Kunshan 215316, Jiangsu, China.
Zhongguo xue xi chong bing fang zhi za zhi = Chinese journal of schistosomiasis control.Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi.2013 Apr;25(2):137-40.
OBJECTIVE: To evaluate the clinical efficiency of tanshinone IIA-sulfonate (STS) in the treatment of liver fibrosis of advanced schistosomiasis.METHODS: A total of 73 advanced schistosomiasis patients were selected into a treatment group and 55 cases of advanced schistosomiasis were selected into a
PMID 23894832

Inhibitory effects of salvianolic acid B on CCl(4)-induced hepatic fibrosis through regulating NF-κB/IκBα signaling.

Wang R, Yu XY, Guo ZY, Wang YJ, Wu Y, Yuan YF.SourceDepartment of Pharmacy, NO.3 People's Hospital affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 201900, China.
Journal of ethnopharmacology.J Ethnopharmacol.2012 Dec 18;144(3):592-8. doi: 10.1016/j.jep.2012.09.048. Epub 2012 Oct 3.
ETHNOPHARMACOLOGICAL RELEVANCE: Hepatic fibrosis, a precursor of liver cirrhosis, is a consequence of severe liver damage that occurs in many patients with chronic liver diseases. Salvianolic acid B (SA-B) is one of water soluble compounds derived from Salvia miltiorrhiza Bunge (Danshen in Chinese)
PMID 23041223

Japanese Journal

インターフェロンβが代償期C型肝硬変の門脈圧, 肝線維化マーカーへ及ぼす影響 : 初期成績

金沢秀典,楢原義之,福田健,近藤千紗,張本滉智,松下洋子,城所秀子,片倉玲樹,厚川正則,中塚雄久,坂本長逸
肝臓 52(1), 7-17, 2011-01-25
… Rとなった．門脈圧の指標としたHVPGは17.5±11.8 mmHgから治療終了時12.4±4.3 mmHgへと29％有意に低下した．肝生検像は治療終了時には2例がF4からF3へ，5例でA因子の改善を認めた．肝線維化マーカー（ヒアルロン酸，PIIIP，IV型コラーゲン，TGF-β1）は何れも治療中有意に低下し，アルブミン，コリンエステラーゼ等は治療中有意に改善した．しかし投与終了1年後には，SVR例では肝線維化マーカー，肝機能の改善が持続したもの …
NAID 10029284744

Cardiac Troponin T vs Other Biochemical Markers in Patients With Congestive Heart Failure

Nishio Yukiko,Sato Yukihito,Taniguchi Ryoji,Shizuta Satoshi,Doi Takahiro,Morimoto Takeshi,Kimura Takeshi,Kita Toru
Circulation journal : official journal of the Japanese Circulation Society 71(5), 631-635, 2007-04-20
… Correlations with other prognostic biochemical markers, including brain natriuretic peptide (BNP), type I collagen C-terminal telopeptide (ICTP), procollagen type HI peptide (PIIIP), renin, norepinephrine (NOREPI), C-reactive protein (CRP), cholesterol, hemoglobin (Hb), uric acid and HbAlc were examined. … Patients with high cTnT had abnormally high blood concentrations of BNP (p<0.0001), ICTP (p<0.0001), PIIIP (p=0.0006), NOREPI (p=0.0119), CRP (p=0.0003), uric acid (p=0.0026) and HbAlc (p=0.0361). …
NAID 110006273594

Related Pictures

LOVE HEART FAKE DOG POOP GIFT Poo Crap Ca Fake Dog Poop, April Fools’ Day Prank During breeding season, it is not uncommon Multi-colored Balls piiip piiip here was the playing list for Klik på det lille billede